Opsoclonus-myoclonus paraneoplastic syndrome in nasopharyngeal carcinoma

Kirsten E. Stewart (Lead / Corresponding author), Martin Zeidler, Devraj Srinivasan, Justin C. L. Yeo

    Research output: Contribution to journalArticlepeer-review

    1 Citation (Scopus)
    136 Downloads (Pure)

    Abstract

    Nasopharyngeal carcinoma can present with epistaxis, cervical lymphadenopathy, audiological symptoms secondary to eustachian tube dysfunction, pain, or neurological symptoms from tumours directly invading the skull base. It is unusual for patients to present with indirect systemic manifestations. Paraneoplastic neurological syndrome can precede clinically overt malignancy by up to 5 years; therefore, a combination of thorough clinical, laboratory and radiological investigations is required to reach a diagnosis. Intravenous immunoglobulin and steroids might improve neurological symptoms initially and prevent irreversible neuronal damage, but treatment of the underlying cancer is important for long-term resolution. Our case adds to a small but growing body of literature related to anti-Ri antibodies, opsoclonus-myoclonus syndrome presentations, and is the first reported association of this combination with nasopharyngeal carcinoma.

    Original languageEnglish
    Article numbere250871
    Number of pages6
    JournalBMJ Case Reports
    Volume15
    Issue number10
    Early online date26 Oct 2022
    DOIs
    Publication statusPublished - Oct 2022

    Keywords

    • Head and neck cancer
    • Immunology
    • Pathology

    ASJC Scopus subject areas

    • General Medicine

    Fingerprint

    Dive into the research topics of 'Opsoclonus-myoclonus paraneoplastic syndrome in nasopharyngeal carcinoma'. Together they form a unique fingerprint.

    Cite this